Societe Generale Asset Management

Total investments

48

Average round size

11M

Portfolio companies

33

Lead investments

4

Follow on index

0.31

Exits

20

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareMedicalDeveloper PlatformPharmaceuticalTherapeuticsSemiconductorWireless

Summary

The leading representative office of defined Corporate Investor is situated in the Paris. The company was established in Europe in France.

Among the most popular portfolio startups of the fund, we may highlight Ekinops, Univa, Genkyotex. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - France.

Besides them, we counted 3 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Societe Generale Asset Management, startups are often financed by Auriga Partners, Ventech, Partech. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Auriga Partners, Partech. In the next rounds fund is usually obtained by Amundi Private Equity Funds, ODYSSEE VENTURE, Ventech.

The fund is constantly included in 2-6 deals per year. The real fund results show that this Corporate Investor is 11 percentage points less often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Societe Generale Asset Management performs on 9 percentage points more the average number of lead investments. The top amount of exits for fund were in 2012. When the investment is from Societe Generale Asset Management the average startup value is 10-50 millions dollars. The top activity for fund was in 2006.

Show more

Investments analytics

Analytics

Total investments
48
Lead investments
4
Exits
20
Follow on index
0.31
Investments by industry
  • Biotechnology (17)
  • Software (10)
  • Information Technology (9)
  • Health Care (8)
  • Semiconductor (8)
  • Show 60 more
Investments by region
  • France (33)
  • United States (11)
  • Germany (1)
  • United Kingdom (1)
  • Switzerland (1)
  • Show 1 more
Peak activity year
2006

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
6M
Group Appearance index
0.88
Avg. company exit year
12
Avg. multiplicator
0.58

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Force-A 09 Nov 2009 Biotechnology, Hardware, Agriculture Early Stage Venture 2M Ile-de-France, France
Jobpartners 01 Apr 2008 Software, Human Resources, Recruiting, SaaS Late Stage Venture 12M England, London, United Kingdom
Notarize 06 May 2015 Real Estate, Software, Mobile, Apps, Legal, Legal Tech Seed 1M United States, Boston, Massachusetts
Two 21 Mar 2023 E-Commerce, Financial Services, FinTech, B2B, Payments Early Stage Venture 21M Oslo, Norway

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.